Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if WVE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
45 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 63 days ago
Red flags: 6
237 filers reported a long position in WVE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156.7M | 27M | Unchanged |
| BlackRock, Inc. | $111.6M | 19.2M | +36% |
| GSK plc | $106M | 18.2M | Unchanged |
| MAVERICK CAPITAL LTD | $59.7M | 10.3M | +1.1% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $31.6M | 5.4M | +0.2% |
| PRIMECAP MANAGEMENT CO/CA/ | $31.1M | 5.4M | +10.8% |
| 683 Capital Management, LLC | $28.8M | 5M | +1% |
| FMR LLC | $28.6M | 4.9M | -5.2% |
| STATE STREET CORP | $28.1M | 4.8M | +31.7% |
| READYSTATE ASSET MANAGEMENT LP | $27.5M | 4.7M | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.